Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03353064 · ClinicalTrials.gov registry record · NA

Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure

A NA study, sponsored by Albert Einstein Healthcare Network.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT03353064: Clinical Trial NA study, sponsored by Albert Einstein Healthcare Network.

NCT03353064 is a NA study that was terminated before completion, run by Albert Einstein Healthcare Network. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03353064, a NA study, was terminated before completion, sponsored by Albert Einstein Healthcare Network.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The Hypercapnia Telemedicine Outreach Program (E-TOUCH Study) aims to utilize telemedicine technology, as well as emergency medical services (EMS) home visits to address the problem with poor follow-up and compliance among Einstein's hypercapnic patients. The hypothesis is that reaching out to the subjects' homes will allow more consistent healthcare delivery, increase healthcare efficiency and compliance with therapy, and overall decrease acute decompensated states / hypercapnic respiratory failure, decreasing ED visits and hospitalization.

Primary Outcome

Patients are followed from enrollment for the next 30 days. We will compare rate of re-admissions between the 2 parallel intervention arms, and check the p-value

Interventions

  • OTHER Vivify
  • OTHER EMS

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2017-10-18
Est. Completion 2018-10-26
Phase NA
Albert Einstein Healthcare Network

48 total trials

Why NCT03353064 stopped before completion

NCT03353064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Vivify is the first listed.

NCT03353064 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03353064 about?

NCT03353064 is a clinical study titled "Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure". The Hypercapnia Telemedicine Outreach Program (E-TOUCH Study) aims to utilize telemedicine technology, as well as emergency medical services (EMS) home visits to address the problem with poor follow-up and compliance among Einstein's hypercapnic patients. The hypothesis is that reaching out to the ...

What is the current status of trial NCT03353064?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-10-18. Estimated completion is 2018-10-26.

What interventions are being tested in trial NCT03353064?

The interventions under investigation include: Vivify (OTHER), EMS (OTHER).

Who is sponsoring clinical trial NCT03353064?

This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03353064's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03353064, the US trial registry maintained by the National Library of Medicine. NCT03353064 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.